Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Assets (2025)

Historic Return on Assets for Silence Therapeutics (SLN) over the last 5 years, with Q3 2025 value amounting to 0.41%.

  • Silence Therapeutics' Return on Assets fell 3000.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of 0.28% for FY2024, which is 1400.0% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Return on Assets is 0.41%, which was down 3000.0% from 0.47% recorded in Q2 2025.
  • Over the past 5 years, Silence Therapeutics' Return on Assets peaked at 0.09% during Q2 2024, and registered a low of 0.47% during Q2 2025.
  • For the 5-year period, Silence Therapeutics' Return on Assets averaged around 0.19%, with its median value being 0.13% (2023).
  • Per our database at Business Quant, Silence Therapeutics' Return on Assets skyrocketed by 1300bps in 2022 and then tumbled by -3800bps in 2025.
  • Over the past 5 years, Silence Therapeutics' Return on Assets (Quarter) stood at 0.24% in 2021, then soared by 51bps to 0.12% in 2022, then fell by -11bps to 0.13% in 2023, then grew by 21bps to 0.1% in 2024, then tumbled by -298bps to 0.41% in 2025.
  • Its Return on Assets was 0.41% in Q3 2025, compared to 0.47% in Q2 2025 and 0.4% in Q1 2025.